LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference

LifeMD, Inc. (Nasdaq: LFMD), a prominent provider of virtual primary care services, has announced its participation in the Canaccord Genuity 45th Annual Growth Conference, scheduled for August 12-14, 2025, at the InterContinental Boston. As part of the event, LifeMD's management will engage in a fireside chat on Wednesday, August 13, at 8:30 a.m. Eastern Time, where they will discuss the company's innovative approaches and growth strategies. Additionally, management will conduct one-on-one meetings with investors on August 12 and 13, allowing for deeper insights into the company’s operations and future directions. Interested investors can register for the conference by reaching out to their Canaccord Genuity representatives.

LifeMD operates as a leader in the telemedicine space, offering a wide range of services that include virtual consultations, laboratory and pharmacy access, and specialized treatment for over 200 conditions. These conditions encompass various areas, including primary care, men’s and women’s health, weight management, and hormone therapy. The company prides itself on its vertically integrated model, which consists of a proprietary digital care platform, a medical group affiliated across all 50 states, an advanced pharmacy connected to its services, and a U.S.-based patient care center. This structure enables LifeMD to enhance access to high-quality, affordable healthcare for its patients.

For more information about LifeMD and its offerings, interested parties can visit LifeMD.com. Those seeking additional details about the conference can reach out to Chief Financial Officer Marc Benathen or Chief Marketing Officer Jessica Friedeman via their provided contact emails.

As LifeMD, Inc. (Nasdaq: LFMD) prepares to participate in the Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025, there are several factors potential investors should consider when evaluating the company’s position in the healthcare market.

LifeMD stands out as a leading provider of virtual primary care, a rapidly growing segment of the healthcare industry. The demand for telemedicine services has surged, especially in the wake of the COVID-19 pandemic, as patients increasingly seek accessible, convenient healthcare solutions. With a proprietary digital care platform and a vertically integrated model that includes telemedicine, lab access, and pharmacy services across more than 200 conditions, LifeMD is well poised for future growth.

During the conference, management's participation in a fireside chat and the scheduled one-on-one investor meetings present valuable opportunities for shareholders and potential investors to gather insights regarding the company's strategies, growth prospects, and financial performance. Investors should pay particular attention to any updates on LifeMD’s expansion plans, partnerships, and technological advancements that could enhance their service offerings and market share.

Moreover, LifeMD’s extensive network of healthcare professionals and a U.S.-based patient care center underscores its commitment to delivering high-quality, affordable care. As healthcare costs continue to rise and patient preferences shift towards digital solutions, LifeMD's integrated approach may establish it as a leader in this sector.

However, investors should also take into account the regulatory landscape and competitive pressures within the telemedicine industry. It is crucial to keep track of any potential changes that could impact LifeMD's operations and profitability.

Overall, LifeMD represents a compelling investment opportunity within the evolving telehealth market. Attending the conference can provide deeper insights and clarity on its future trajectory.